Malignant tumors remain a major threat to human health, and conventional treatments and first-generation immune checkpoint inhibitors (ICIs) face limitations…

In 2025, the European Medicines Agency approved two antibodies for Alzheimer’s disease: lecanemab (LeqembiTM, manufactured by Biogen) and donanemab (KisunlaTM,…

Sleep apnea is significantly more severe on weekends than on weekdays, and the effects are even greater in people who…

A recent antitrust ruling will force Takeda to revise its financials for 2025, with the pharmaceutical company expected to report…

Healthcare platform Fullspan Health has deployed a conversational artificial intelligence agent that can answer consumers’ health-related inquiries and connect them…